2017 Australasian HIV & AIDS Conference joint with 2017 Australasian Sexual Health Conference National Convention Centre Canberra 6 – 9 November 2017

HIV&AIDS Late Breaker Abstract Guidelines


Late Breaker Abstract Submissions are now CLOSED


Abstract Guidelines PDF
Research-Based Abstract Template


In order for your presentation to be considered, abstract guidelines must be followed as closely as possible. Please ensure that the presenting author completes the abstract submission. Abstracts must be submitted by the deadline of Sunday 13 August 2017.

Authors should state a preference for oral or poster presentation, and address the abstract to one of the conference themes below.

Late Breakers are open for Theme A ONLY

Clarification of theme A is below.

Abstract submissions are encouraged from and about groups most affected by HIV and related infections including but not limited to:

  • Aboriginal and Torres Strait Islander and Global Indigenous Populations
  • People living with HIV (PLHIV)
  • Gay identified and other men who have sex with men (MSM)
  • Migrant and refugee populations
  • Women
  • People with transgender experience
  • Children and young people
  • People who inject drugs
  • Sex workers

We encourage submission in HIV, co-infection, HTLV-1 and related infections

Theme Explanation
Theme A: Understanding and identifying HIV and related infections: Basic Science,
Biology and Pathogenesis.

This theme explores fundamentals of HIV and
laboratory based research and practice. Areas
of focus include the translation of basic
research to clinical and laboratory based
practice in Australia and the Region.

• Mechanisms of viral replication
• Viral diversity and bioinformatics
• Virus – host interactions in productive or
restricted infection
• Viral latency and reservoirs
• Immunology and pathogenesis
• Biomarkers of disease outcome
• Drug development
• Vaccines (therapeutic and prophylactic)
• Immune-based therapies
• Microbicides and Biomedical prevention strategies
• Gene therapy
• Diagnostics
• Community perspectives on

Presentation Type

Presentation Type Time Allocation Explanation
RESEARCH BASED ORAL PRESENTATION 12 minutes presentation and
3 minutes question time
Oral presentations on original research findings, case studies, completed projects and theoretical analyses. Presentations should be well structured, rigorous and demonstrate a novel contribution to knowledge.
POSTER PRESENTATION Permanently displayed during
the conference
Posters will be displayed within the exhibition and catering area. A number of top ranked posters in each theme will be allocated a 6 minute oral presentation (4 minute presentation and 2 minutes question time) in rapid fire sessions.

Abstract Preparation Guidelines for all Presentations:

All abstracts must:

  • Use Arial 12 point type only
  • Use single spacing only
  • Format - Microsoft Word (.doc) file only
  • Leave one line between paragraphs
  • Specify all abbreviations in full at the first mention, followed by the abbreviation in parentheses, thereafter abbreviation only should be used
  • Be written in English
  • Check abstract thoroughly for spelling and grammar
  • Do not include references

NOTE: There are two (2) abstract template options
RESEARCH BASED Abstract Template

All abstracts must include:

TITLE: in BOLD at the top of the abstract


  • Principal author to appear first
  • Underline the name of the author who will be presenting the paper
  • Use surname followed by initials (do not use full stops or commas between surname and initials)
  • Omit degrees and titles
  • Include affiliations for each author. Use superscript numbering after the author’s name to indicate affiliations


BODY OF ABSTRACT: maximum 300 words, with following headings:

  • Background: study objectives, hypothesis tested, or description of problem
  • Methods: method used or approach taken (e.g. study population, data collection methods, statistical analyses and/or theoretical approach)
  • Results: in summarised form, must include data (e.g. statistics or qualitative data) but do not include tables, graphs or pictures. Include results/outcomes and results of statistical tests such a p values, odds or hazard ratios and confidence intervals.
  • Conclusion: description of main outcomes and implications of the study. Highlight the novelty of findings and how they contribute to evidence-based practice. Include knowledge or insight that conference attendees will gain from the presentation, explanation of how conference attendees can apply the skills and/or knowledge within their communities and how the study contributes to evidence-based knowledge


The Australasian Society for HIV Medicine, Viral Hepatitis & Sexual Health Medicine recognises the considerable contribution that industry partners make to professional and research activities. We also recognise the need for transparency of disclosure of potential conflicts of interest by acknowledging these relationships in publications and presentations.

For an example of a disclosure of interest statement please see below:

"The Melon Institute and Metabolism Corp are funded by the University of Oxbridge, UK. No pharmaceutical grants were received in the development of this study"

Note: If accepted into the program you will be requested to include a disclosure of interest slide into your presentation or include such statements in your poster.

Selection Criteria:

Abstracts will be favoured at review if they incorporate

  • Completed rather than future work
  • Original data of high quality
  • An analysis that extends existing knowledge
  • Clarity of methodology, analysis and presentation of results
  • Specific rather than general finding

In balancing the program the committee may require authors to present their work in an alternate format (e.g. as a poster rather than oral presentation).

Note: We encourage abstracts based on Indigenous issues be presented by Indigenous persons, or an Indigenous co-presenter be included. If this is not possible, please include some information as to whether any member of the indigenous community in which the research is based was involved in development of the research protocol or in conducting the research.

Late Breaker Abstract Submission:

Abstracts must be submitted electronically through the online abstract submission site. You will be required to enter:

  • Preferred theme
  • Preferred presentation type
  • Authors’ names (indicate presenting author and contact details - address, telephone and email). Note: Abstract presenters will be required to fund their own attendance at the conference and should not submit an abstract if this is not possible. Scholarships are available and preference will be given to those who do submit abstracts, however authors should ensure they are able to fund their own travel if need be
  • Authors’ affiliations
  • Abstract title
  • Abstract as a word document (maximum 300 words) plus a disclosure of interest statement
  • Short biography of presenter (maximum 50 words). This information will be used by the session chair for introduction purposes and may be published in conference literature
  • Special audio visual requirements

Please contact the Conference Secretariat if you are unable to lodge your abstract via the website or if you have any queries. By submitting an abstract all authors agree to release the licence to the Conference organisers and give permission to publish the abstract in the conference handbook and on the website and, in so doing, certify that the abstract is original work.

Conference Registration:

Late breaker abstract presenters will be required to fund their own attendance at the conference and should not submit an abstract if this is not possible.

Late Breaker presenters (including posters) will be required to register for the conference by Saturday 30 September 2017. It will be assumed that any presenter not registered by this date has withdrawn from the program and their abstract will be removed from the handbook.

Disclaimer: The committee may place your presentation within another theme while developing the best fit sessions.